3 Firms Build Biotech Merger With $150M In Private Funding
Biopharmaceutical company Werewolf Therapeutics and clinical-stage biotechnology firm Ambros Therapeutics have agreed to merge in an all-stock deal built by three law firms, and includes $150 million in private funding....To view the full article, register now.
Already a subscriber? Click here to view full article